Developing models for studying infectious diseases like Ebola in non-human primates.
Task B16: Model Development and Medical Countermeasures (MCMs) for BSL-4 Agents in NHPs
This study is looking at how we can better understand and treat infectious diseases like Ebola by using non-human primates, which could eventually lead to new treatments that help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-11197719 on NIH RePORTER |
What this research studies
This research focuses on creating and improving models using non-human primates to better understand infectious diseases, particularly Ebola. By evaluating potential medical countermeasures, the research aims to identify effective treatments and preventive strategies. Patients may benefit indirectly through advancements in therapies that emerge from this work, as it seeks to enhance our understanding of how these diseases affect living organisms. The approach involves rigorous testing and evaluation of candidate therapeutic agents in a controlled environment.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at risk of contracting infectious diseases like Ebola or those involved in healthcare and research related to these conditions.
Not a fit: Patients with non-infectious diseases or those not at risk for infectious diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective treatments and vaccines for severe infectious diseases.
How similar studies have performed: Previous research has shown success in developing models for infectious diseases, indicating that this approach has potential for significant advancements.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Beasley, David — University of Texas Med Br Galveston
- Study coordinator: Beasley, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.